High Tech Pharm Co., Ltd. (KOSDAQ:106190)

South Korea flag South Korea · Delayed Price · Currency is KRW
19,310
-410 (-2.08%)
At close: Apr 28, 2026
47.52%
Market Cap 205.33B
Revenue (ttm) 70.18B
Net Income (ttm) 11.48B
Shares Out 10.63M
EPS (ttm) n/a
PE Ratio 17.89
Forward PE n/a
Dividend 150.00 (0.76%)
Ex-Dividend Date Dec 29, 2025
Volume 41,552
Average Volume 65,677
Open 19,720
Previous Close 19,720
Day's Range 19,180 - 19,720
52-Week Range 10,700 - 25,000
Beta 0.19
RSI 50.31
Earnings Date May 14, 2026

About High Tech Pharm

High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1998
Employees 65
Stock Exchange KOSDAQ
Ticker Symbol 106190
Full Company Profile

Financial Performance

In 2025, High Tech Pharm's revenue was 70.18 billion, a decrease of -9.46% compared to the previous year's 77.51 billion. Earnings were 11.48 billion, a decrease of -16.30%.

Financial Statements

News

There is no news available yet.